Literature DB >> 5456173

Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.

G R Breese, T D Traylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5456173      PMCID： PMC3055658     

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  28 in total

1.  An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine.

Authors:  J P Tranzer; H Thoenen
Journal:  Experientia       Date:  1968-02-15

2.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

3.  Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.

Authors:  J J Schildkraut; S M Schanberg; G R Breese; I J Kopin
Journal:  Am J Psychiatry       Date:  1967-11       Impact factor: 18.112

4.  Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

Authors:  S M Schanberg; J J Schildkraut; G R Breese; I J Kopin
Journal:  Biochem Pharmacol       Date:  1968-02       Impact factor: 5.858

5.  Degeneration of adrenergic nerves produced by 6-hydroxydopamine.

Authors:  T Malmfors; C Sachs
Journal:  Eur J Pharmacol       Date:  1968-04       Impact factor: 4.432

6.  The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity.

Authors:  G C Sedvall; V K Weise; I J Kopin
Journal:  J Pharmacol Exp Ther       Date:  1968-02       Impact factor: 4.030

7.  Adrenal tyrosine hydroxylase: compensatory increase in activity after chemical sympathectomy.

Authors:  R A Mueller; H Thoenen; J Axelrod
Journal:  Science       Date:  1969-01-31       Impact factor: 47.728

8.  A sensitive and specific fluorescence assay for tissue serotonin.

Authors:  S H Snyder; J Axelrod; M Zweig
Journal:  Biochem Pharmacol       Date:  1965-05       Impact factor: 5.858

9.  Distribution of tyrosine hydroxylase activity in adult and developing brain.

Authors:  E G McGeer; S Gibson; J A Wada; P L McGeer
Journal:  Can J Biochem       Date:  1967-12

10.  The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain.

Authors:  S M Schanberg; J J Schildkraut; I J Kopin
Journal:  Biochem Pharmacol       Date:  1967-02       Impact factor: 5.858
View more
  75 in total

1.  Partial selectivity of 6-OHDA induced neuronal degeneration after intraissular injection in the brain with special reference to the nigro-striatal dopamine system.

Authors:  F Javoy
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease.

Authors:  Sherri L Thiele; Ruth Warre; Joanne E Nash
Journal:  J Vis Exp       Date:  2012-02-14       Impact factor: 1.355

3.  SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.

Authors:  G R Breese; R A Mueller
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

4.  Recovery of brain noradrenaline after 5,7-dihydroxytryptamine-induced axonal lesions in the rat.

Authors:  A Björklund; H G Baumgarten; L Lachenmayer; E Rosengren
Journal:  Cell Tissue Res       Date:  1975-08-18       Impact factor: 5.249

5.  Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.

Authors:  D S Reynolds; R J Carter; A J Morton
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

6.  6-hydroxydopamine lesions enhance progesterone-facilitated lordosis of rats and hamsters, independent of effects on motor behavior.

Authors:  Cheryl A Frye; Sandra M Petralia; Madeline E Rhodes; Joseph F DeBold
Journal:  Physiol Behav       Date:  2009-09-22

7.  Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity.

Authors:  M G Ondrusek; C D Kilts; G D Frye; R B Mailman; R A Mueller; G R Breese
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Effect of 6-hydroxydopamine on electrical self stimulation of the brain.

Authors:  G R Breese; J L Howard; J P Leahy
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

9.  Dissociable effects of 6-OHDA-induced lesions of neostriatum on anorexia, locomotor activity and stereotypy: the role of behavioural competition.

Authors:  E M Joyce; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Effects of brain monoamine depletion on thermoregulation, active avoidance, and food and water intake in rats.

Authors:  M T Lin; W Y Chia; C T Tsai; T H Yin
Journal:  Experientia       Date:  1978-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.